Dissolved and financials
CVR: 21144347
DKK 52,902
Gross profit
Net result: DKK -2,089,315
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 26 November 2014
CVR · view overview
2 employees
CVR · 2009
Director role ended: Thomas Nielsen
CVR · 26/11/2014
View the full event history
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 1998. The company has been dissolved on 26 November 2014. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 2 employees (2009). In 2013, the company reported a gross profit of DKK 52,902 and a net result of DKK -2,089,315. Equity in the 2013 report amounted to DKK -648,075.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201301/01/2013 – 31/12/2013 | 53 t. | -2.1 mio. | 1.5 mio. | -648 t. | - | |
| 201201/01/2012 – 31/12/2012 | - | - | - | 1 mio. | - |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. NORDIC BIOSCIENCE CLINICAL STUDIES A/S is registered in the Danish CVR register with the status Dissolved and ceased on 26 November 2014.
The CVR number of NORDIC BIOSCIENCE CLINICAL STUDIES A/S is 21144347.
In 2013, NORDIC BIOSCIENCE CLINICAL STUDIES A/S reported a gross profit of DKK 52,902.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S had 2 employees in 2009 according to the Danish CVR register.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was founded on 1 June 1998.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
NORDIC BIOSCIENCE CLINICAL STUDIES A/S has published its interim report for the period January 1, 2014 – November 7, 2014.
As of November 26, 2014, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of November 26, 2014, Thomas Nielsen has stepped down as liquidator of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
On November 26, 2014, NORDIC BIOSCIENCE CLINICAL STUDIES A/S exited liquidation.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was dissolved on November 26, 2014.
As of July 2, 2014, Bente Juel Christiansen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of July 2, 2014, Morten Asser Karsdal has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of July 2, 2014, Thomas Nielsen is registered as liquidator of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of July 2, 2014, Claus Henrik Christiansen has stepped down as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of July 2, 2014, Thomas Nielsen has stepped down as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
On July 2, 2014, NORDIC BIOSCIENCE CLINICAL STUDIES A/S entered liquidation.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S has published its annual report for 2013. Gross profit came to DKK 52,902, and the net result was DKK -2,089,315.
As of January 2, 2014, Morten Asser Karsdal has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 2, 2014, Hervé Girsault has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S has published its annual report for 2012.
As of February 6, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of February 6, 2013, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 2, 2013, Hervé Girsault has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 2, 2013, Thomas Nielsen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Thomas Nielsen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Niels Lolk Helveg Petersen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Herbert Schmidt has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, David H Mac Callum has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Hervé Girsault has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Claus Henrik Christiansen is registered as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Thomas Nielsen is registered as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Claus Henrik Christiansen has stepped down as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 22, 2010, Peter Degnboel Thostrup has stepped down as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 3, 2006, A/S PSE 13 NR. 1304 has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 13, 2005, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 13, 2005, CJ Partnership I/S has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 13, 2005, Hervé Girsault has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 3, 2004, Bente Juel Christiansen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 3, 2004, Claus Henrik Christiansen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 3, 2004, Peter Degnboel Thostrup is registered as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 19, 2003, Niels Lolk Helveg Petersen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 19, 2003, Niels Thomas Heering has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 19, 2003, Erik Gregers Hansen has stepped down as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of April 4, 2003, Claus Henrik Christiansen is registered as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of April 4, 2003, Klaus Eldrup-Jørgensen has stepped down as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 22, 2002, Asger Domino has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of May 13, 2002, CJ Partnership I/S has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 1, 2002, Klaus Eldrup-Jørgensen is registered as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 1, 2002, Niels Tækker Foged has stepped down as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 1, 2002, Herman Jan Tijmen Coelingh Bennink has stepped down as adm. dir of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of December 18, 2001, Asger Domino has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of December 18, 2001, Herbert Schmidt has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of December 18, 2001, David H Mac Callum has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of October 1, 2000, Herman Jan Tijmen Coelingh Bennink is registered as adm. dir of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of December 21, 1999, Henrik Lawaetz has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 14, 1999, Erik Gregers Hansen is registered as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of April 27, 1999, Henrik Daniel Lawaetz Arhnung has stepped down as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, A/S PSE 13 NR. 1304 has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Karl-Alfred Brylle has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Henrik Lawaetz has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Niels Thomas Heering has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Claus Henrik Christiansen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Victor Christoffersen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Sebastian Benjamin Bahn Christoffersen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Helen Mimi Janniche has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Niels Tækker Foged is registered as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Henrik Daniel Lawaetz Arhnung is registered as chairman of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of March 15, 1999, Victor Christoffersen has stepped down as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 1, 1998, Karl-Alfred Brylle has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 1, 1998, Victor Christoffersen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 1, 1998, Sebastian Benjamin Bahn Christoffersen has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 1, 1998, Helen Mimi Janniche has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of June 1, 1998, Victor Christoffersen is registered as direktion of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was founded on June 1, 1998.
